124 filings
Page 5 of 7
8-K
yecfndnyaw
5 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
q7wa4mdh0z215 kmuj
22 Jan 18
Regulation FD Disclosure
12:00am
8-K
tdzr1r
12 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
n41hqp7
21 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
dpatx0qs6949powud
6 Nov 17
Flex Pharma Reports Third Quarter 2017 Financial Results
12:00am
8-K
xzyll 0qbw0b8spjj3kv
2 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
jp0o52dyzslk83rrvyht
25 Sep 17
Regulation FD Disclosure
12:00am
8-K
fxdt79gbcto wo5jws43
28 Aug 17
Departure of Directors or Certain Officers
12:00am
8-K
t82luypt2nlz
2 Aug 17
Flex Pharma Reports Second Quarter 2017 Financial Results
12:00am
8-K
fxtvhvlegtrhlg28m i3
11 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
jqf8dg8
6 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
fhf8sq ap62jyafe
3 May 17
Flex Pharma Reports First Quarter 2017 Financial Results
12:00am
8-K
oa3hz0tt18e739zfgz
5 Apr 17
Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
12:00am
8-K
uma7gauz5qq
8 Mar 17
Flex Pharma Reports Year End 2016 Financial Results
12:00am
8-K
bj0p8ig
23 Feb 17
Regulation FD Disclosure
12:00am
8-K
1ztlj0h8
2 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
fvz1a 56w
15 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
b29gr8
15 Nov 16
Regulation FD Disclosure
12:00am
8-K
qryy9xkd2ntu33
2 Nov 16
Flex Pharma Reports Third Quarter 2016 Financial Results
12:00am
8-K
oi0lkh75oma zu2t7la
13 Oct 16
Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
12:00am